2-(2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}ethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

Catalog No. :
ACKVKT552
CAS No. :
861206-88-4
Molecular Formula :
C21H24N4O4
Molecular Weight :
396.45

IUPAC Name:2-(2-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)ethyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

2-(2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}ethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}ethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one
IUPAC Name2-(2-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)ethyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
Molecular FormulaC21H24N4O4
Molecular Weight396.45
SMILESO=C1NC2=NC=CC=C2OC1CCN3CCN(CC4=CC=C(OCO5)C5=C4)CC3
InChI KeyGZLRHWWXBQPKJZ-UHFFFAOYSA-N
Synonym2-(2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}ethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one;2-(2-[4-(1,3-BENZODIOXOL-5-YLMETHYL)PIPERAZINO]ETHYL)-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE;2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 2-[2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]ethyl]-
CAS No.861206-88-4

Synthetic Route by SureRoute

1. ACKVKT552 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKVKT552 route product structure diagram
    ACKVKT552861206-88-4
Inquiry

2. ACKVKT552 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKVKT552 route product structure diagram
    ACKVKT552861206-88-4
Inquiry

Comments (0)